us-ftc-hsr-informal-interpretations-b2617b14331a0f5845a96ed63bc14fa4•0605023 Informal Interpretation
0605023 Informal Interpretation
us-ftc-hsr-informal-interpretations-b2617b14331a0f5845a96ed63bc14fa40605023 Informal InterpretationGuidance
Question
From:(redacted)
Sent:Monday, May 22, 2006 3:56 PM
To:Verne, B. Michael
Subject:HSR 801.40 Question
Aquestion regarding 801.40:
A forms a new corporation, Newco,to acquire 100% of the non-corporate interests of B for $200 million.
C(B's CEO) will acquire 100% of Newco's voting securities for $5 million.
Awill loan Newco $200 million to acquire B. In exchange, A will hold Newcoconvertible voting and nonvoting securities.
(1)A is a $113.4+ million person.
(2)Newco is a newly-formed entity without abalance sheet, no assets and is its own UPE until after closing (after closingC will be B's only UPE).
(3)B is a $113.4+ million person.
(4)C (B's CEO) assets are unknown so far.
Ouranalysis is as follows:
Under 801.40, even if the special size-of-personthresholds are met, no filing is required because:
- although A is an acquiring person and a contributor(Int. #179), A is exempt from reporting because of the 802.31 exemption(acquisitions of convertible voting securities).
- B is an acquiring person and a contributor (Int.#179) but B's acquisition of Newco's voting securities for $5 million does notmeet the size-of-the-transaction threshold.
Undera traditional acquisitions analysis (non-801.40), a filing is not requiredbecause:
- Newco does not meet either size-of-person thresholdas its only assets are to be used to acquire B (and it does not have aregularly-prepared balance sheet)
- A's acquisition of Newco's convertible votingsecurities is exempt under 802.31.
Is our analysis correct?
Ti chiedi come si applica questo testo alla tua situazione?
Consulenza gratuita, senza impegno
Descrivi la tua situazione. Il nostro team ti ricontatterà via e-mail per la tua consulenza.
Continua la tua ricerca in ChatGPT o Claude
Collega Omnilex per cercare nel corpus legale dal tuo assistente IA.